当前位置:
X-MOL 学术
›
Acta Physiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
BGP-15: A potential therapeutic agent for critical illness myopathy.
Acta Physiologica ( IF 5.6 ) Pub Date : 2020-01-11 , DOI: 10.1111/apha.13441 Takashi Yamada 1
Acta Physiologica ( IF 5.6 ) Pub Date : 2020-01-11 , DOI: 10.1111/apha.13441 Takashi Yamada 1
Affiliation
In the current issue of Acta Physiologica, Larsson and colleagues examined the effect of chaperone co‐inducer BGP‐15 on impaired contractile function of the slow‐twitch soleus muscles in a rat intensive care unit (ICU) model.1 They found that BGP‐15 improves myofibrillar function in the soleus muscle after 5 days exposure to the ICU condition, which is accompanied by improved mitochondrial morphology/biogenesis and reduced oxidative post‐translational modifications (PTMs) of myosin molecules.
中文翻译:
BGP-15:重症肌病的潜在治疗剂。
在当前一期《生理生理学》中,Larsson及其同事在大鼠重症监护病房(ICU)模型中检查了伴侣伴侣诱导剂BGP-15对慢肌比目鱼肌收缩功能受损的影响。1他们发现,在ICU条件下暴露5天后,BGP-15改善了比目鱼肌的肌原纤维功能,并伴有线粒体形态/生物发生的改善和肌球蛋白分子的氧化翻译后修饰(PTM)的减少。
更新日期:2020-01-13
中文翻译:
BGP-15:重症肌病的潜在治疗剂。
在当前一期《生理生理学》中,Larsson及其同事在大鼠重症监护病房(ICU)模型中检查了伴侣伴侣诱导剂BGP-15对慢肌比目鱼肌收缩功能受损的影响。1他们发现,在ICU条件下暴露5天后,BGP-15改善了比目鱼肌的肌原纤维功能,并伴有线粒体形态/生物发生的改善和肌球蛋白分子的氧化翻译后修饰(PTM)的减少。